Breadcrumb

Banner - Infectious Diseases and Immunity in Global Health Program -IDIGH

IDIGH  |  Infectious Diseases and Immunity in Global Health Program

IDIGH News heading

News

Asset Publisher

Three COVID-19 projects at the RI-MUHC to receive CIHR funding

A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease

COVID-19 pandemic: Looking back to better tackle future challenges

In two recent studies, RI-MUHC researchers provide useful information for evaluating public health strategies

Innovation Moves Online for the 2020 McGill Clinical Innovation Competition

RI-MUHC research team, Emily McDonald and Todd C. Lee, ties for Marika Zelenka Roy Innovation Prize

COVID-19 impact on cancer patients: MUHC researchers take part in a multinational study

Published in The Lancet, the study reveals cancer-specific factors associated with increased mortality

Hydroxychloroquine not effective in preventing the development of COVID-19 when used as post-exposure prophylaxis

A new study suggests that hydroxychloroquine is not effective in preventing the development of COVID-19 in individuals exposed to SARS-CoV-2

Results of MI4 Emergency COVID-19 Research Funding (Round 2)

RI-MUHC researchers awarded MUHC Foundation funding for a second round of projects with potential impact in a short timeframe

Looking to produce a COVID-19 vaccine in the greenhouse

RI-MUHC researcher working with Quebec-based company on a plant-based technique

We Care About Rare!

Researchers, advocates and patients gather on Rare Disease Research Day at the RI-MUHC

RI-MUHC researchers review diagnostic tests for COVID-19

Study published in the Annals of Internal Medicine

Results of MI4 Emergency COVID-19 Research Funding (Round 1)

RI-MUHC researchers awarded MUHC Foundation funding for projects with potential impact in a short timeframe

FRQ to create a province-wide COVID-19 Biobank

RI-MUHC researchers take leading roles in the initiative

$4 M for MUHC Foundation COVID-19 Emergency Fund

Prominent Montreal families come together to fight the pandemic

Reducing confusion about the coronavirus (COVID-19)

RI-MUHC researchers provide expertise and advice

RI-MUHC innovative clinical trial assesses hydroxychloroquine for prevention and treatment of COVID-19

Initially restricted to health care workers in Quebec, the clinical study is now open to all eligible adults

COVID-19 coronavirus and tuberculosis: We need a damage control plan

Dr. Madhukar Pai explains why TB services might be one of the biggest casualties of the pandemic

RI-MUHC researcher on Innovation Panel at the U.S. National Academy of Sciences

Dr. Nitika Pant Pai speaks out on global microbial threats

Vitamin E effective, safe for fatty liver in HIV patients

RI-MUHC researcher Dr. Giada Sebastiani is lead author of study published in the journal AIDS

Overcoming the greatest obstacle to curing HIV

RI-MUHC researcher participated in the groundbreaking study published in Nature

The Pfizer Investigator Training Program comes to the RI-MUHC!

Clinical research educational training program benefits researchers, staff and students at the inaugural event

See Archive - IDIGH